Post-Traumatic Headache Clinical Trial
Official title:
A Multidisciplinary Translational Approach to Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence. The objective of the clinical trial component of the Focused Program is to determine whether intervention with erenumab is an effective treatment for PTH attributed to mTBI.
The human studies component of this Focused Program includes clinical phenotyping, neurophysiology, molecular and genetic biomarker discovery, brain imaging, and a clinical trial.These data will be utilized to characterize post-traumatic headache and build univariate and multivariate predictive models for post-traumatic headache persistence and for the response to post-traumatic headache treatment. These studies are described in more detail within a separate clinicaltrials.gov record. The clinical trial is a double-blind, randomized, placebo-controlled investigation of erenumab for the treatment of post-traumatic headache. Participants will be randomized when PTH has been present for 35-56 days. Follow-up questionnaires, headache diary data, pain threshold results, and brain imaging data will be collected longitudinally during the clinical trial to assess for changes over time and associations of such changes with post-traumatic headache treatment outcomes. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04369729 -
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
|
||
| Completed |
NCT03588364 -
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
|
N/A | |
| Recruiting |
NCT05378074 -
Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache
|
N/A | |
| Recruiting |
NCT05328635 -
Post-traumatic Headache Multidisciplinary Study
|
||
| Completed |
NCT04776304 -
Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms
|
N/A | |
| Recruiting |
NCT04614922 -
Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms
|
N/A | |
| Recruiting |
NCT05595993 -
Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache
|
N/A | |
| Completed |
NCT03674398 -
Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology
|
N/A | |
| Completed |
NCT02965027 -
Prazosin for Post-Concussive Headaches
|
Phase 4 | |
| Active, not recruiting |
NCT05635656 -
Digital Solutions for Concussion
|
N/A | |
| Recruiting |
NCT06015451 -
Exercise in Postconcussion Symptoms and Posttraumatic Headache
|
N/A | |
| Recruiting |
NCT04906603 -
Theta Burst Stimulation for Headaches After Traumatic Brain Injury
|
N/A | |
| Terminated |
NCT01053507 -
Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction
|
Phase 4 | |
| Completed |
NCT02419131 -
Cognitive-Behavior Therapy for Posttraumatic Headache
|
N/A | |
| Terminated |
NCT03806985 -
Effects of Psilocybin in Concussion Headache
|
Phase 1 | |
| Completed |
NCT05243953 -
Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache
|
N/A | |
| Completed |
NCT03056352 -
Metoclopramide for Post-Traumatic Headache. A Pilot Study
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06132529 -
A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache
|
||
| Completed |
NCT01854385 -
Sumatriptan as Treatment for Post-traumatic Headache
|
Phase 2 | |
| Completed |
NCT03523923 -
TBI Care: Collaborative Care for Pain After Traumatic Brain Injury (TBI)
|
N/A |